TSHA logo

TSHA
Taysha Gene Therapies Inc

2,044
Mkt Cap
$1.93B
Volume
654,871.00
52W High
$6.73
52W Low
$1.70
PE Ratio
-18.64
TSHA Fundamentals
Price
$6.61
Prev Close
$6.72
Open
$6.65
50D MA
$4.75
Beta
1.67
Avg. Volume
3.13M
EPS (Annual)
-$0.3409
P/B
7.76
Rev/Employee
$98,717.17
$1,508.72
Loading...
Loading...
News
all
press releases
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 12-Month High - Should You Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Reaches New 1-Year High - Here's What Happened...
MarketBeat·19h ago
News Placeholder
More News
News Placeholder
Taysha Gene Therapies Sees Unusually High Options Volume (NASDAQ:TSHA)
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) was the target of some unusual options trading on Thursday. Stock investors acquired 6,277 call options on the company. This is an increase...
MarketBeat·7d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Sets New 12-Month High - Still a Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Hits New 52-Week High - What's Next...
MarketBeat·7d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 9% - Should You Buy?
Taysha Gene Therapies (NASDAQ:TSHA) Stock Price Up 9% - Still a Buy...
MarketBeat·8d ago
News Placeholder
Taysha Gene Therapies, Inc. (NASDAQ:TSHA) Given Average Rating of "Buy" by Brokerages
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) has received an average rating of "Buy" from the thirteen brokerages that are presently covering the firm, MarketBeat reports. One equities...
MarketBeat·8d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Insider Sells $892,000.00 in Stock
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the business's stock in a transaction dated Friday, April 10th. The shares were sold at an...
MarketBeat·9d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Insider Sukumar Nagendran Sells 200,000 Shares
Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Get Free Report) insider Sukumar Nagendran sold 200,000 shares of the company's stock in a transaction dated Friday, April 10th. The shares were sold at an average price of $4.46, for a total transaction of $892,000.00. Following the sale, the insider...
MarketBeat·10d ago
News Placeholder
Aberdeen Group plc Purchases Shares of 1,021,063 Taysha Gene Therapies, Inc. $TSHA
Aberdeen Group plc purchased a new stake in shares of Taysha Gene Therapies, Inc. (NASDAQ:TSHA - Free Report) during the 4th quarter, according to the company in its most recent filing with the...
MarketBeat·14d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Shares Up 6.9% on Analyst Upgrade
Taysha Gene Therapies (NASDAQ:TSHA) Trading Up 6.9% on Analyst Upgrade...
MarketBeat·17d ago
News Placeholder
Taysha Gene Therapies (NASDAQ:TSHA) Price Target Raised to $17.00
Canaccord Genuity Group upped their price objective on Taysha Gene Therapies from $14.00 to $17.00 and gave the stock a "buy" rating in a research note on Monday...
MarketBeat·17d ago
<
1
2
...
>

Latest TSHA News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.